D. Yu. Kanner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
D. Yu. Kanner has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
- Dmitry Suraev
Moscow City Oncology Hospital No. 62
5 shared publications - Oksana V. Paklina
Vishnevsky National Medical Research Center of Surgery
5 shared publications - Dmitry Valerievich Kalinin
A.V. Vishnevsky National Medical Research Center of Surgery
3 shared publications - Nikita A. Savelov
Moscow City Oncology Hospital No. 62
3 shared publications - E. F. Kim
Moscow City Oncological Hospital No. 62, Moscow Healthcare Department, Surgical Department of Oncocoloproctology
2 shared publications - E. M. Chir-Chir
Moscow City Oncological Hospital No. 62, Moscow Healthcare Department, Surgical Department of Oncocoloproctology
2 shared publications
Latest Publications
- Open Access
- 10 August 2026
- Published by "MedINK" Publishing House
- Vol. 1 (2) , 73-79
Robot-assisted antegrade intersphincteric resection: A case from practice at the Moscow City Oncology Hospital No. 62
Background . Treatment of low tumors of the rectum remains one of the most complex oncological problems. If a tumor is ultra-low and specific anatomical characteristics of the pelvis are identified, organ-sparing surgery in the framework of the standard laparoscopic access becomes exacting due to rigidity of the instruments, while combined abdominoperineal resection is associated with additional risks. In robot-assisted access, the instruments have much higher motion degrees of freedom which allows to overcome difficulties caused by complex anatomy, size and site of the tumor. Aim . To demonstrate benefits of organ-sparing robot-assisted antegrade intersphincteric resection in patients with narrow and deep pelvis using a real clinical case. Clinical case . A 50‑year-old patient was admitted to the Oncological Proctology Division of the Moscow City Oncology Hospital No. 62 with adenocarcinoma of the lower rectal ampulla (cT3N1M0). Magnetic resonance imaging showed features of the pelvis making standard intervention difficult. Following neoadjuvant chemoradiotherapy without a significant pathological response, a fully transabdominal robot-assisted (da Vinci Xi) intersphincteric rectal resection was performed. Distinctive features of the procedure were absence of the perineal stage, colonic pull-through and delayed (on day 7) coloanal anastomosis formation without a temporary stoma. This technique allowed the avoid extirpation while achieving oncological radicality (ypT3N0R0). Functional outcomes at 6 months corresponded to a Wexner score of 12. Conclusion . This approach, based on strict magnetic resonance imaging data on the features of the pelvis allows to spare the anal sphincter preservation in patients with ultra-low tumors in the setting of challenging pelvic anatomy.
- 10 August 2026
- Published by "MedINK" Publishing House
- Vol. 1 (2) , 73-79
Open AccessRobot-assisted antegrade intersphincteric resection: A case from practice at the Moscow City Oncology Hospital No. 62
Background . Treatment of low tumors of the rectum remains one of the most complex oncological problems. If a tumor is ultra-low and specific anatomical characteristics of the pelvis are identified, organ-sparing surgery in the framework of the standard laparoscopic access becomes exacting due to rigidity of the instruments, while combined abdominoperineal resection is associated with additional risks. In robot-assisted access, the instruments have much higher motion degrees of freedom which allows to overcome difficulties caused by complex anatomy, size and site of the tumor. Aim . To demonstrate benefits of organ-sparing robot-assisted antegrade intersphincteric resection in patients with narrow and deep pelvis using a real clinical case. Clinical case . A 50‑year-old patient was admitted to the Oncological Proctology Division of the Moscow City Oncology Hospital No. 62 with adenocarcinoma of the lower rectal ampulla (cT3N1M0). Magnetic resonance imaging showed features of the pelvis making standard intervention difficult. Following neoadjuvant chemoradiotherapy without a significant pathological response, a fully transabdominal robot-assisted (da Vinci Xi) intersphincteric rectal resection was performed. Distinctive features of the procedure were absence of the perineal stage, colonic pull-through and delayed (on day 7) coloanal anastomosis formation without a temporary stoma. This technique allowed the avoid extirpation while achieving oncological radicality (ypT3N0R0). Functional outcomes at 6 months corresponded to a Wexner score of 12. Conclusion . This approach, based on strict magnetic resonance imaging data on the features of the pelvis allows to spare the anal sphincter preservation in patients with ultra-low tumors in the setting of challenging pelvic anatomy.
- 30 July 2026
- Published by Media Sphere Publishing Group in Russian Journal of Archive of Pathology
- Vol. 88 (4)
Molecular genetic characteristics of epithelial neoplasia of extrahepatic bile ducts
Objective. To determine the molecular genetic characteristics of the epithelial neoplasia of extrahepatic bile ducts (EHD) depending on the degree of epithelial dysplasia in order to identify mutations that facilitate their differential diagnosis. Material and methods. The study included 44 EHD biopsies containing epithelial neoplasms and cholangiocarcinoma. All samples underwent massive parallel sequencing of DNA isolated from 10-μm-thick histological sections. Mutations of categories I-III of clinical significance were considered. Statistical analysis of the obtained data utilized a two-tailed Pearson χ2 test with Holm’s correction for multiple comparisons (p<0.045). Results. The most frequent mutations in epithelial neoplasia of the EHD were identified: MYC, KRAS, PIK3CA, CDKN2A, ERBB2, KIT 6, TP53 6, FBXW7, POLE and TERT. The highest proportion of mutations was in biliary intraepithelial neoplasia and cholangiocarcinoma. Among epithelial neoplasia and cholangiocarcinoma, mutations in KRAS, POLE and TERT differed significantly. KRAS (p<0.045) — BilIN LG and BilIN HG, IPNB HG and cholangiocarcinoma; POLE (p<0.045) — BilIN LG and cholangiocarcinoma; TERT (p<0.045) — BilIN LG and cholangiocarcinoma. Specificity and sensitivity indicators for KRAS were 28 and 50%; POLE — 35 and 100%; TERT — 100 and 100%. Conclusion. Mutations have been identified that should be considered in the differential diagnosis of the degree of epithelial dysplasia and the types of epithelial neoplasia of the extrahepatic bile ducts.
- 30 July 2026
- Published by Media Sphere Publishing Group in Russian Journal of Archive of Pathology
- Vol. 88 (4)
Molecular genetic characteristics of epithelial neoplasia of extrahepatic bile ducts
Objective. To determine the molecular genetic characteristics of the epithelial neoplasia of extrahepatic bile ducts (EHD) depending on the degree of epithelial dysplasia in order to identify mutations that facilitate their differential diagnosis. Material and methods. The study included 44 EHD biopsies containing epithelial neoplasms and cholangiocarcinoma. All samples underwent massive parallel sequencing of DNA isolated from 10-μm-thick histological sections. Mutations of categories I-III of clinical significance were considered. Statistical analysis of the obtained data utilized a two-tailed Pearson χ2 test with Holm’s correction for multiple comparisons (p<0.045). Results. The most frequent mutations in epithelial neoplasia of the EHD were identified: MYC, KRAS, PIK3CA, CDKN2A, ERBB2, KIT 6, TP53 6, FBXW7, POLE and TERT. The highest proportion of mutations was in biliary intraepithelial neoplasia and cholangiocarcinoma. Among epithelial neoplasia and cholangiocarcinoma, mutations in KRAS, POLE and TERT differed significantly. KRAS (p<0.045) — BilIN LG and BilIN HG, IPNB HG and cholangiocarcinoma; POLE (p<0.045) — BilIN LG and cholangiocarcinoma; TERT (p<0.045) — BilIN LG and cholangiocarcinoma. Specificity and sensitivity indicators for KRAS were 28 and 50%; POLE — 35 and 100%; TERT — 100 and 100%. Conclusion. Mutations have been identified that should be considered in the differential diagnosis of the degree of epithelial dysplasia and the types of epithelial neoplasia of the extrahepatic bile ducts.
- 27 July 2026
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 7
Comparative analysis of intracorporeal and extracorporeal anastomotic techniques in laparoscopic right colectomy: assessment of surgical safety and short-term outcome
Background. Restoration of intestinal continuity after laparoscopic right colectomy may be performed with either intracorporeal (IA) or extracorporeal (EA) anastomosis. The surgical safety of IA remains under active investigation. The aim of this study was to evaluate the outcomes of IA in oncological patients undergoing laparoscopic right colectomy. Methods. A retrospective cohort study was conducted using a prospectively maintained database (June 2018 — December 2023), including patients with colon cancer who underwent laparoscopic right colectomy. Surgical outcomes were compared between the IA and EA groups. Results. A total of 701 patients were included: 649 in the IA group and 52 in the EA group. The groups were comparable in terms of age (p=0.353), sex (p=0.418), body mass index (p=0.583), and number of comorbidities (p=0.784). Earlier recovery of bowel function was observed in the IA group: median of 4 vs. 5 days to first stool (p<0.001). Anastomotic leak rates did not differ significantly between the IA and EA groups: 1.5% vs. 5.8% (p=0.065). Major postoperative complications (Clavien—Dindo ≥IIIA) occurred significantly less frequently with IA: 6.3% vs. 23.1% (p<0.001). IA was associated with a reduced risk of major complications, with an odds ratio of 0.31 (95% CI: 0.14—0.69) after adjustment for other factors. In subgroup analysis, the association between IA and fewer major postoperative complications was most pronounced in patients with obesity: odds ratio of 0.08 (95% CI: 0.02—0.30). Conclusion. Intracorporeal anastomosis in laparoscopic right colectomy is associated with faster recovery of bowel function, does not increase the risk of anastomotic leakage, and reduces the rate of major postoperative complications, particularly in patients with obesity. Mastery of the IA technique may become an important component of colorectal surgical training, offering patients a more favourable postoperative course.
- 27 July 2026
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 7
Comparative analysis of intracorporeal and extracorporeal anastomotic techniques in laparoscopic right colectomy: assessment of surgical safety and short-term outcome
Background. Restoration of intestinal continuity after laparoscopic right colectomy may be performed with either intracorporeal (IA) or extracorporeal (EA) anastomosis. The surgical safety of IA remains under active investigation. The aim of this study was to evaluate the outcomes of IA in oncological patients undergoing laparoscopic right colectomy. Methods. A retrospective cohort study was conducted using a prospectively maintained database (June 2018 — December 2023), including patients with colon cancer who underwent laparoscopic right colectomy. Surgical outcomes were compared between the IA and EA groups. Results. A total of 701 patients were included: 649 in the IA group and 52 in the EA group. The groups were comparable in terms of age (p=0.353), sex (p=0.418), body mass index (p=0.583), and number of comorbidities (p=0.784). Earlier recovery of bowel function was observed in the IA group: median of 4 vs. 5 days to first stool (p<0.001). Anastomotic leak rates did not differ significantly between the IA and EA groups: 1.5% vs. 5.8% (p=0.065). Major postoperative complications (Clavien—Dindo ≥IIIA) occurred significantly less frequently with IA: 6.3% vs. 23.1% (p<0.001). IA was associated with a reduced risk of major complications, with an odds ratio of 0.31 (95% CI: 0.14—0.69) after adjustment for other factors. In subgroup analysis, the association between IA and fewer major postoperative complications was most pronounced in patients with obesity: odds ratio of 0.08 (95% CI: 0.02—0.30). Conclusion. Intracorporeal anastomosis in laparoscopic right colectomy is associated with faster recovery of bowel function, does not increase the risk of anastomotic leakage, and reduces the rate of major postoperative complications, particularly in patients with obesity. Mastery of the IA technique may become an important component of colorectal surgical training, offering patients a more favourable postoperative course.
- 16 April 2026
- Published by Media Sphere Publishing Group in Russian Journal of Archive of Pathology
- Vol. 88 (2) , 72-79
Differential diagnostics of inflammatory changes and epithelial neoplasia of extrahepatic bile ducts
Objective. To investigate the histological and immunohistochemical characteristics of epithelial neoplasia of the extrahepatic bile ducts (EHBD) and to develop a diagnostic algorithm. Material and methods. The study included 104 patients. All patients underwent biliary tract biopsy. Morphological and immunohistochemical parameters were compared in biopsies with inflammation, low- and high-grade biliary intraepithelial neoplasia (BilIN), low- and high-grade intraductal papillary neoplasia (IPNB), and cholangiocarcinoma (CC). The main parameters in the study of the histological characteristics of epithelial neoplasia of the EHBD were: cellular atypia, nuclear polymorphism, nuclear polarity, the state of the brush border, inflammatory infiltration, and histological architecture. Immunohistochemical studies were performed using antibodies to MUC1, MUC2, MUC5AC, MUC6, and CD10. When studying the IHC characteristics of epithelial neoplasms of the EHBD, the localization of the reaction in epithelial cells, its intensity, and prevalence were assessed, and specificity and sensitivity were evaluated. Statistical analysis of the data used the two-sided Pearson χ2 criterion (p<0.05). Results. Based on the results of the morphological stage of the study, a scale for assessing the degree of dysplasia in biopsy specimens was developed; a certain number of points were assigned to each type of epithelial neoplasia of the EHBD. Based on the results of the IHC study, taking into account statistically significant changes, an immunophenotype was established for each type of epithelial neoplasia of the EHBD: inflammation and BilIN LG — MUC1, MUC2, MUC6, CD10; BilIN HG — MUC1, MUC2, MUC5AC, MUC6; IPNB LG — MUC1, MUC2, MUC5AC, MUC6, CD10; IPNB HG — MUC1, MUC2, MUC5AC, MUC6; CC — MUC1, MUC5AC, MUC6. For differential diagnosis of the degree of dysplasia in epithelial neoplasia of the EHBD, it is recommended to use an IHC panel with the presence of antibodies to MUC1, MUC2, CD10. It is proposed to use antibodies to MUC2, MUC5AC and MUC6 as an IHC panel for differential diagnosis of IPNB subtypes. Conclusion. Clear morphological and immunohistochemical criteria for the differential diagnosis of non-invasive lesions of the EHBD, inflammation and cholangiocarcinoma have been identified, and an algorithm for the comprehensive differential diagnosis of epithelial neoplasia of the EHBD has been developed.
- 16 April 2026
- Published by Media Sphere Publishing Group in Russian Journal of Archive of Pathology
- Vol. 88 (2) , 72-79
Differential diagnostics of inflammatory changes and epithelial neoplasia of extrahepatic bile ducts
Objective. To investigate the histological and immunohistochemical characteristics of epithelial neoplasia of the extrahepatic bile ducts (EHBD) and to develop a diagnostic algorithm. Material and methods. The study included 104 patients. All patients underwent biliary tract biopsy. Morphological and immunohistochemical parameters were compared in biopsies with inflammation, low- and high-grade biliary intraepithelial neoplasia (BilIN), low- and high-grade intraductal papillary neoplasia (IPNB), and cholangiocarcinoma (CC). The main parameters in the study of the histological characteristics of epithelial neoplasia of the EHBD were: cellular atypia, nuclear polymorphism, nuclear polarity, the state of the brush border, inflammatory infiltration, and histological architecture. Immunohistochemical studies were performed using antibodies to MUC1, MUC2, MUC5AC, MUC6, and CD10. When studying the IHC characteristics of epithelial neoplasms of the EHBD, the localization of the reaction in epithelial cells, its intensity, and prevalence were assessed, and specificity and sensitivity were evaluated. Statistical analysis of the data used the two-sided Pearson χ2 criterion (p<0.05). Results. Based on the results of the morphological stage of the study, a scale for assessing the degree of dysplasia in biopsy specimens was developed; a certain number of points were assigned to each type of epithelial neoplasia of the EHBD. Based on the results of the IHC study, taking into account statistically significant changes, an immunophenotype was established for each type of epithelial neoplasia of the EHBD: inflammation and BilIN LG — MUC1, MUC2, MUC6, CD10; BilIN HG — MUC1, MUC2, MUC5AC, MUC6; IPNB LG — MUC1, MUC2, MUC5AC, MUC6, CD10; IPNB HG — MUC1, MUC2, MUC5AC, MUC6; CC — MUC1, MUC5AC, MUC6. For differential diagnosis of the degree of dysplasia in epithelial neoplasia of the EHBD, it is recommended to use an IHC panel with the presence of antibodies to MUC1, MUC2, CD10. It is proposed to use antibodies to MUC2, MUC5AC and MUC6 as an IHC panel for differential diagnosis of IPNB subtypes. Conclusion. Clear morphological and immunohistochemical criteria for the differential diagnosis of non-invasive lesions of the EHBD, inflammation and cholangiocarcinoma have been identified, and an algorithm for the comprehensive differential diagnosis of epithelial neoplasia of the EHBD has been developed.
- 18 June 2025
- Published by Media Sphere Publishing Group in Russian Journal of Archive of Pathology
- Vol. 87 (3) , 71-76
Solitary fibrous tumor of common bile duct: case report and literature review
Solitary fibrous tumor (SFT) is a rare mesenchymal tumor. SFT was first described by Klemperer and Rabin in 1931. They described a fibrous tumor of the pleura. Currently, isolated cases of SFT of the gallbladder and common bile duct have been described in the world. SFT is characterized by nuclear expression of STAT6 and the formation of chimeric genes NAB2-STAT6. A case report of a rare SFT of the common bile duct in a 66-year-old patient is presented. The description contains data from radiation and ultrasound diagnostic methods, macro- and microscopic characteristics of the tumor and immunohistochemical characteristics.
- 18 June 2025
- Published by Media Sphere Publishing Group in Russian Journal of Archive of Pathology
- Vol. 87 (3) , 71-76
Solitary fibrous tumor of common bile duct: case report and literature review
Solitary fibrous tumor (SFT) is a rare mesenchymal tumor. SFT was first described by Klemperer and Rabin in 1931. They described a fibrous tumor of the pleura. Currently, isolated cases of SFT of the gallbladder and common bile duct have been described in the world. SFT is characterized by nuclear expression of STAT6 and the formation of chimeric genes NAB2-STAT6. A case report of a rare SFT of the common bile duct in a 66-year-old patient is presented. The description contains data from radiation and ultrasound diagnostic methods, macro- and microscopic characteristics of the tumor and immunohistochemical characteristics.
- 12 February 2025
- Published by Media Sphere Publishing Group in Russian Journal of Archive of Pathology
- Vol. 87 (1) , 41-47
Neuroendocrine tumor of the extrahepatic bile ducts. Case report and literature review
Neuroendocrine neoplasms (NENs) are heterogeneous tumors with a common phenotype. There are two fundamentally different groups of NENs: well differentiated with a low proliferative index, called neuroendocrine tumors (NETs) and poorly differentiated with a high proliferative index, called neuroendocrine carcinoma (NEC). Extrahepatic bile duct NETs (EBNETs) account for 0.2% to 2% of all gastrointestinal NETs and up to 2% of all malignant neoplasms of the extrahepatic bile ducts. To date, 114 cases of EBNETs have been described, with disease-free survival ranging from 2 to 240 months. In most cases, the tumors expressed Chromogranin A, Synaptophysin, CD56, and NSE. This report presents a rare case of an EBNET in a 61-year-old patient following resection of the extrahepatic bile ducts. The description includes data from radiological and ultrasound diagnostic methods, macro- and microscopic characteristics of the tumor, and immunohistochemical profile.
- 12 February 2025
- Published by Media Sphere Publishing Group in Russian Journal of Archive of Pathology
- Vol. 87 (1) , 41-47
Neuroendocrine tumor of the extrahepatic bile ducts. Case report and literature review
Neuroendocrine neoplasms (NENs) are heterogeneous tumors with a common phenotype. There are two fundamentally different groups of NENs: well differentiated with a low proliferative index, called neuroendocrine tumors (NETs) and poorly differentiated with a high proliferative index, called neuroendocrine carcinoma (NEC). Extrahepatic bile duct NETs (EBNETs) account for 0.2% to 2% of all gastrointestinal NETs and up to 2% of all malignant neoplasms of the extrahepatic bile ducts. To date, 114 cases of EBNETs have been described, with disease-free survival ranging from 2 to 240 months. In most cases, the tumors expressed Chromogranin A, Synaptophysin, CD56, and NSE. This report presents a rare case of an EBNET in a 61-year-old patient following resection of the extrahepatic bile ducts. The description includes data from radiological and ultrasound diagnostic methods, macro- and microscopic characteristics of the tumor, and immunohistochemical profile.
- Open Access
- 15 January 2025
- Published by Publishing House ABV Press in Advances in molecular oncology
- Vol. 12 (1) , 96-108
Proteomic analysis of blood plasma as a tool for personalized diagnosis of lung adenocarcinoma
Introduction. Lung cancer ranks second in incidence and first in mortality among other oncological pathologies. Despite significant success in the diagnosis and treatment of tumors, the five-year survival rate for lung cancer is only 19 % and has not improved significantly in recent decades, which is mainly associated with late detection of the disease. In addition, the development of metastases reduces the five-year survival rate to 6 %.Aim. To analyze the plasma proteome of healthy volunteers and patients with lung adenocarcinoma (LAC), as one of the most common forms of lung cancer, to identify proteins that are potential biomarkers of LAC and of the presence of distant metastases.Materials and methods. The study included 30 healthy donors and 30 patients with diagnosed LAC. using a combination of liquid chromatography and tandem mass spectrometry in combination with the method of multiple reactions monitoring, we analyzed the representation of a wide range of proteins in the blood plasma of the study participants. The data obtained were analyzed using modern methods of biological statistics, including machine learning algorithms.Results. Based on the quantitative analysis of 118 proteins in blood plasma between the experimental groups, we proposed a panel of 12 significant proteins that are specific markers of LAC. Additionally, we identified three proteins that predict the presence of distant metastases among patients with LAC. Classifiers developed based on these protein panels make it possible to distinguish between patients with LAC and healthy controls, as well as to detect the presence of metastases among patients with LAC, with sensitivity and specificity of more than 90 %.Conclusion. The data obtained can be used to develop new tests for LAC screening and predicting disease outcomes based on the blood plasma proteome. After additional validation and implementation into clinical practice, these tests can contribute to the early diagnosis of LAC and, as a result, increase patient survival.
- 15 January 2025
- Published by Publishing House ABV Press in Advances in molecular oncology
- Vol. 12 (1) , 96-108
Open AccessProteomic analysis of blood plasma as a tool for personalized diagnosis of lung adenocarcinoma
Introduction. Lung cancer ranks second in incidence and first in mortality among other oncological pathologies. Despite significant success in the diagnosis and treatment of tumors, the five-year survival rate for lung cancer is only 19 % and has not improved significantly in recent decades, which is mainly associated with late detection of the disease. In addition, the development of metastases reduces the five-year survival rate to 6 %.Aim. To analyze the plasma proteome of healthy volunteers and patients with lung adenocarcinoma (LAC), as one of the most common forms of lung cancer, to identify proteins that are potential biomarkers of LAC and of the presence of distant metastases.Materials and methods. The study included 30 healthy donors and 30 patients with diagnosed LAC. using a combination of liquid chromatography and tandem mass spectrometry in combination with the method of multiple reactions monitoring, we analyzed the representation of a wide range of proteins in the blood plasma of the study participants. The data obtained were analyzed using modern methods of biological statistics, including machine learning algorithms.Results. Based on the quantitative analysis of 118 proteins in blood plasma between the experimental groups, we proposed a panel of 12 significant proteins that are specific markers of LAC. Additionally, we identified three proteins that predict the presence of distant metastases among patients with LAC. Classifiers developed based on these protein panels make it possible to distinguish between patients with LAC and healthy controls, as well as to detect the presence of metastases among patients with LAC, with sensitivity and specificity of more than 90 %.Conclusion. The data obtained can be used to develop new tests for LAC screening and predicting disease outcomes based on the blood plasma proteome. After additional validation and implementation into clinical practice, these tests can contribute to the early diagnosis of LAC and, as a result, increase patient survival.
- 1 January 2025
- Published by FSBSI Research Institute of Human Morphology in CLINICAL AND EXPERIMENTAL MORPHOLOGY
- Vol. 14 (2)
Precancerous changes of extrahepatic bile ducts: biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct
Stenosis of extrahepatic bile ducts is a significant diagnostic problem in clinical practice. Up to 40% of extrahepatic bile duct stenoses are due to biliary intraepithelial neoplasia (BilIN) and intraductal papillary neoplasm (IPNB). The risk of developing cholangiocellular carcinoma against the background of BilIN and IPNB increases 160 times. The mutation of the KRAS gene has been shown to be the predictor of the transition of BilIN and IPNB to cholangiocellular carcinoma. Histological examination of biopsy material plays a crucial role in diagnosing stenosis. There have already been established criteria for assessing the degree of dysplasia in BilIN and IPNB, IPNB subtypes, and the most common and characteristic mutations in BilIN and IPNB. Moreover, immunohistochemical markers were recommended to determine the type/subtype of stenosis and assess the degree of epithelial dysplasia. Until now, lesions of extrahepatic gallbladder as a cause of stenosis or precancerous processes are one of the most pressing topics in hepatopancreatobiliary pathology. Thus, at this stage, it is necessary to develop simple algorithms for histological diagnosis, identify and introduce into practice additional methods of morphological research. Keywords: stenosis, biliary intraepithelial neoplasia, intraductal papillary neoplasm, dysplasia, mutations, immunohistochemical diagnosis
- 1 January 2025
- Published by FSBSI Research Institute of Human Morphology in CLINICAL AND EXPERIMENTAL MORPHOLOGY
- Vol. 14 (2)
Precancerous changes of extrahepatic bile ducts: biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct
Stenosis of extrahepatic bile ducts is a significant diagnostic problem in clinical practice. Up to 40% of extrahepatic bile duct stenoses are due to biliary intraepithelial neoplasia (BilIN) and intraductal papillary neoplasm (IPNB). The risk of developing cholangiocellular carcinoma against the background of BilIN and IPNB increases 160 times. The mutation of the KRAS gene has been shown to be the predictor of the transition of BilIN and IPNB to cholangiocellular carcinoma. Histological examination of biopsy material plays a crucial role in diagnosing stenosis. There have already been established criteria for assessing the degree of dysplasia in BilIN and IPNB, IPNB subtypes, and the most common and characteristic mutations in BilIN and IPNB. Moreover, immunohistochemical markers were recommended to determine the type/subtype of stenosis and assess the degree of epithelial dysplasia. Until now, lesions of extrahepatic gallbladder as a cause of stenosis or precancerous processes are one of the most pressing topics in hepatopancreatobiliary pathology. Thus, at this stage, it is necessary to develop simple algorithms for histological diagnosis, identify and introduce into practice additional methods of morphological research. Keywords: stenosis, biliary intraepithelial neoplasia, intraductal papillary neoplasm, dysplasia, mutations, immunohistochemical diagnosis
- Open Access
- 2 May 2024
- Published by N.N. Blokhin Cancer Fund in Surgery and Oncology
- Vol. 14 (1) , 62-71
Efficacy of total neoadjuvant chemotherapy in the FLOT regimen in patients with locally advanced gastric and gastroesophageal junction: results of a phase II study
Background. The established approach notably improving the therapeutic outcomes for locally advanced gastric cancer and gastroesophageal junction cancer, presently entails the amalgamation of perioperative chemotherapy aligned with the FLOT protocol and surgical intervention. However, this approach harbors limitations, as only half of the patient cohort successfully completes the entire prescribed course of drug therapy. The potential solution to this problem lies in the complete transfer of the chemotherapy volume to the preoperative period and the execution of total neoadjuvant chemotherapy with FLOT regimen.Aim. Aim is to conduct a comparative assessment of the efficacy and safety between total neoadjuvant and perioperative chemotherapy with FLOT regimen for patients with locally advanced gastric cancer and gastroesophageal junction cancer.Materials and methods. In a retrospective study we enrolled patients with histologically confirmed locally advanced gastric cancer and gastroesophageal junction cancer meeting clinical stage criteria T2–4 and N0–3, without of distant metastases, treated between 2014 and 2020 at Federal State Budgetary Institution “N. N. Blokhin National Medical Research Center of Oncology” оf the Ministry of Health of the Russian Federation and Moscow City Oncologic Hospital No. 62 Department of Healthcare of Moscow. Participants in the control group underwent 8 courses of perioperative chemotherapy (4 preoperatively and 4 postoperatively), while those in the experimental group received 8 courses of total neoadjuvant chemotherapy. Both groups received drug therapy according to the FLOT protocol: 5-fluorouracil 2600 mg/m2 , intravenous drip, over 24 hours, leucovorin 200 mg/m2 , intravenous drip, oxaliplatin 85 mg/m2 , intravenous drip, docetaxel 50 mg/m2 , intravenous drip, on day 1, with a 14-day intercourse interval. The primary endpoint was one-year progression-free survival.Results. In the study included 187 patients. Participants were divided into two groups: 95 in the total neoadjuvant chemotherapy group and 92 in the perioperative chemotherapy group. The one-year progression-free survival was higher in the total neoadjuvant chemotherapy group at 79 %, compared to 68 % in the perioperative chemotherapy group (HR 0.54, 95 % confidence interval 0.32–0.9, p = 0.02). Median disease-free survival was 27.2 and 19.5 months in the neoadjuvant and perioperative chemotherapy groups, respectively. The tolerability of the entire planned drug treatment regimen was superior in the total neoadjuvant chemotherapy group, reaching 88.4 %, as opposed to 57.6 % in the perioperative chemotherapy group (p = 0.0001).Conclusion. Among patients with locally advanced gastric cancer and gastroesophageal junction cancer, the application of total neoadjuvant chemotherapy according to the FLOT protocol, administered over 8 courses, demonstrated enhanced one-year progression-free survival and improved tolerability of the entire planned treatment regimen.
- 2 May 2024
- Published by N.N. Blokhin Cancer Fund in Surgery and Oncology
- Vol. 14 (1) , 62-71
Open AccessEfficacy of total neoadjuvant chemotherapy in the FLOT regimen in patients with locally advanced gastric and gastroesophageal junction: results of a phase II study
Background. The established approach notably improving the therapeutic outcomes for locally advanced gastric cancer and gastroesophageal junction cancer, presently entails the amalgamation of perioperative chemotherapy aligned with the FLOT protocol and surgical intervention. However, this approach harbors limitations, as only half of the patient cohort successfully completes the entire prescribed course of drug therapy. The potential solution to this problem lies in the complete transfer of the chemotherapy volume to the preoperative period and the execution of total neoadjuvant chemotherapy with FLOT regimen.Aim. Aim is to conduct a comparative assessment of the efficacy and safety between total neoadjuvant and perioperative chemotherapy with FLOT regimen for patients with locally advanced gastric cancer and gastroesophageal junction cancer.Materials and methods. In a retrospective study we enrolled patients with histologically confirmed locally advanced gastric cancer and gastroesophageal junction cancer meeting clinical stage criteria T2–4 and N0–3, without of distant metastases, treated between 2014 and 2020 at Federal State Budgetary Institution “N. N. Blokhin National Medical Research Center of Oncology” оf the Ministry of Health of the Russian Federation and Moscow City Oncologic Hospital No. 62 Department of Healthcare of Moscow. Participants in the control group underwent 8 courses of perioperative chemotherapy (4 preoperatively and 4 postoperatively), while those in the experimental group received 8 courses of total neoadjuvant chemotherapy. Both groups received drug therapy according to the FLOT protocol: 5-fluorouracil 2600 mg/m2 , intravenous drip, over 24 hours, leucovorin 200 mg/m2 , intravenous drip, oxaliplatin 85 mg/m2 , intravenous drip, docetaxel 50 mg/m2 , intravenous drip, on day 1, with a 14-day intercourse interval. The primary endpoint was one-year progression-free survival.Results. In the study included 187 patients. Participants were divided into two groups: 95 in the total neoadjuvant chemotherapy group and 92 in the perioperative chemotherapy group. The one-year progression-free survival was higher in the total neoadjuvant chemotherapy group at 79 %, compared to 68 % in the perioperative chemotherapy group (HR 0.54, 95 % confidence interval 0.32–0.9, p = 0.02). Median disease-free survival was 27.2 and 19.5 months in the neoadjuvant and perioperative chemotherapy groups, respectively. The tolerability of the entire planned drug treatment regimen was superior in the total neoadjuvant chemotherapy group, reaching 88.4 %, as opposed to 57.6 % in the perioperative chemotherapy group (p = 0.0001).Conclusion. Among patients with locally advanced gastric cancer and gastroesophageal junction cancer, the application of total neoadjuvant chemotherapy according to the FLOT protocol, administered over 8 courses, demonstrated enhanced one-year progression-free survival and improved tolerability of the entire planned treatment regimen.
- Open Access
- 19 June 2023
- Published by Research Institute for Healthcare Organization and Medical Management in City Healthcare
- Vol. 4 (2)
Capabilities of Molecular Genetic Methods for Effective Hereditary Cancers Detection in Individuals with High Cancer Risk Factors
Russia and other countries report an increase in the incidence of malignant neoplasms, and approximately 10 % of all oncological cases have hereditary background. Molecular genetic testing in patients with diagnosed malignant neoplasms and a suspected hereditary factor will help to select effective modern methods of treatment and prevention of the development of neoplasms of other localizations. According to the study, 12,6 % of patients had hereditary cancer syndrome, which allowed to administer molecular genetic tests to patients’ relatives. Consequently, it becomes possible to detect hereditary cancer risk factors, improve the efficiency of clinical examination, elaborate and implement programs for prevention and early detection of the disease.
- 19 June 2023
- Published by Research Institute for Healthcare Organization and Medical Management in City Healthcare
- Vol. 4 (2)
Open AccessCapabilities of Molecular Genetic Methods for Effective Hereditary Cancers Detection in Individuals with High Cancer Risk Factors
Russia and other countries report an increase in the incidence of malignant neoplasms, and approximately 10 % of all oncological cases have hereditary background. Molecular genetic testing in patients with diagnosed malignant neoplasms and a suspected hereditary factor will help to select effective modern methods of treatment and prevention of the development of neoplasms of other localizations. According to the study, 12,6 % of patients had hereditary cancer syndrome, which allowed to administer molecular genetic tests to patients’ relatives. Consequently, it becomes possible to detect hereditary cancer risk factors, improve the efficiency of clinical examination, elaborate and implement programs for prevention and early detection of the disease.